HEXO Corp. (HEXO.TO)

0.8700 +0.0100 (+1.16%) At close: 3:59PM EDT

HEXO Corp.

490 Boulevard Saint-Joseph
Suite 204
Gatineau, QC J8Y 3Y7
Canada
844-406-1852
http://www.hexocorp.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Sébastien G. St-Louis	Co-Founder, Pres, CEO & Director	486.21k	N/A	1984
Mr. Stephen Harry-Donald Burwash	Chief Financial Officer	2.58M	N/A	N/A
Mr. Roch Vaillancourt	Gen. Counsel	396.18k	N/A	N/A
Ms. Dominique Jones	Chief People Officer	355.16k	N/A	1968
Mr. Michael P. Monahan	Consultant	477.85k	N/A	1972

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. HEXO Corp. is headquartered in Gatineau, Canada.

Corporate Governance

HEXO Corp.’s ISS Governance QualityScore as of December 9, 2019 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.